The QX-314-Bromide Market is estimated to be USD 251 million in 2020 with a CAGR of 5% during the forecast period 2022-2028. QX Bromide is a quaternary derivative of lidocaine, a voltage-activated Na+ channel blocker. Calcium currents in hippocampal CA1 pyramidal neurons are also inhibited by intracellular QX bromide. As an alternative to trichlorethylene and […]
